SEC Form 4 · accession 0001615774-17-004890

Vivani Medical, Inc. · VANI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Aug 30, 2017

Accepted (ET)

Aug 31, 2017 · 5:17 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001266806

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Aug 18, 2017	M	11,875	$0.97	A	78,907	D
Common Stock^F2	Aug 30, 2017	D	4,921	$1.08	D	73,986	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Unit (RSU)^F5,F4,F3	—	Aug 30, 2017	M	11,875	D	Aug 17, 2016	Aug 17, 2019	Common Stock	190,000	95,000	D
Warrant to Purchase Common Stock	$1.47	holding	—	—	—	Mar 14, 2017	Mar 14, 2022	Common Stock	6,794	6,794	D
Non-Qualified Stock Option (right to buy)^F3	$1.97	holding	—	—	—	Jan 3, 2018	Jan 3, 2027	Common Stock	571,330	571,330	D
Non-Qualified Stock Option (right to buy)^F3	$4.10	holding	—	—	—	Jan 21, 2017	Jan 21, 2026	Common Stock	21,290	21,290	D
Non-Qualified Stock Option (right to buy)^F3	$12.43	holding	—	—	—	Aug 17, 2016	Aug 17, 2025	Common Stock	420,000	420,000	D

F111,875 shares of common stock acquired upon quarterly vesting of Restricted Stock Units (RSUs).
F24,921 shares were sold to satisfy the tax withholding requirements on vesting of RSUs.
F3Options and RSUs vest over a 4 year term, with 25% vesting on the Date Exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%.
F4Each restricted stock unit represents a contingent right to receive one share of common stock of the Company.
F5Not Applicable.